Core fucosylation and IgG function in NAIT
- PMID: 24458274
- PMCID: PMC3901063
- DOI: 10.1182/blood-2013-12-539965
Core fucosylation and IgG function in NAIT
Abstract
In this issue of Blood, Kapur et al show that maternal human platelet-specific antigen 1a (HPA 1a)-specific antibodies causing neonatal alloimmune thrombocytopenia (NAIT) possess oligosaccharides that are deficient in "core fucose" residues and appear to be more effective than fucosylated antibodies in promoting phagocytosis of antibody-coated platelets.
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interests.
Figures
Comment on
-
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.Blood. 2014 Jan 23;123(4):471-80. doi: 10.1182/blood-2013-09-527978. Epub 2013 Nov 15. Blood. 2014. PMID: 24243971 Free PMC article.
References
-
- Jefferis R. Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol Sci. 2009;30(7):356–362. - PubMed
-
- Shields RL, Lai J, Keck R, et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem. 2002;277(30):26733–26740. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
